Upcoming Events


September 17, 2020 , 08:00 am - 12:30 pm

This FREE Workshop is brought to you by Providers Clinical Support System and Washington State Department of Health virtually via Zoom.

Click RSVP to register. 


Completion of this free 4 hour live virtual course followed by a 4 hour online course allows physicians to apply for the waiver to prescribe buprenorphine for treatment of opioid use disorder. ARNPs and PA-Cs require a 16 hour online course.

Non-prescriber OUD (Opioid Use Disorder) care team members, including RNs and Substance Use Disorder Professionals, are encouraged to attend.

Learning Objectives:

  • Screen and identify patients with OUD and define evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss all FDA approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.


As the class begins promptly, please arrive ten minutes early. Those who arrive late may be asked to leave without credit.

Those that arrive more than 15 minutes late to class, may not be let in from the waiting room, and will not receive a certificate of completion.

After registration is received, an Outlook Invitation with details and the exact location will be sent. Accept the invitation and we will know you are coming. If you do not receive an Outlook Invitation in three to five days, please contact us. We do not allow drop-ins.

Please contact the Training Department at least ten days prior to the training if you require special accommodations.

Cancellations must be emailed and received no later than seven days prior to the event. If we cancel the training, registrants will be offered the next class.

Funding for this training made possible in part by  grant number 1H79TI081968 from SAMHSA and Cooperative Agreement Number NU17CE925007, funded by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Centers for Disease Control and Prevention Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.